查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1865723

伽马探针设备市场报告：趋势、预测和竞争分析（至2031年）

Gamma Probe Device Market Report: Trends, Forecast and Competitive Analysis to 2031
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

由于医院和门诊手术中心市场蕴藏着巨大机会，全球伽玛探针设备市场前景看好。预计2025年至2031年，全球伽玛探针设备市场将以8.7%的复合年增长率成长。推动该市场成长的关键因素包括：对精准手术需求的不断增长、癌症病例的持续增加以及微创手术的日益普及。

  • Lucintel预测，在预测期内，行动端将实现所有模式中最高的成长率。
  • 按最终用途划分，预计门诊手术中心将呈现更高的成长率。
  • 从区域来看，预计亚太地区在预测期内将达到最高的成长率。

伽玛探针设备市场的新趋势

受诸多新兴趋势的影响，伽玛探针市场正经历重大变革，这些趋势强调精准性、整合性和易用性。在微创手术、提高诊断灵敏度和改善患者预后（尤其是在肿瘤领域）的持续需求驱动下，这些趋势正在革新伽玛探针的设计、功能和应用，从小型化到人工智慧的应用，无一例外。这些创新从根本上改变了伽玛探针的设计、功能和应用，为更有效率、更有效的放射导航手术铺平了道路。

  • 小型化和便携化：这一趋势旨在开发更小、更轻，有时甚至是无线的伽玛探头，从而提高手术室内的操作灵活性，并实现更符合人体工学的设计。小型化使得微创手术技术得以应用，并提高了操作弹性，尤其是在狭小的解剖腔内。携带式和手持式设备的趋势增强了其多功能性，使其能够应用于各种类型的手术和不同的手术环境。这最大限度地减少了对笨重推车式系统的需求，并提高了外科医生手术的灵活性和效率。
  • 无线和无线技术：无线和无线伽玛探头的普及是未来一项重要的发展趋势，它将提高手术的灵活性并改善手术室的整洁度。这项技术减少了线缆的杂乱，使外科医生能够更灵活地操作，并最大限度地降低复杂手术过程中发生污染和线缆缠绕的风险。无线连接实现了显示器之间的无缝数据传输，使手术流程更加高效便捷，为医务人员创造了一个更轻鬆、更安全的工作环境。
  • 与机器人手术系统整合：未来最重要的发展趋势之一是将伽玛探针与机器人手术系统无缝整合。这将使外科医生能够在机器人环境中利用伽马探针的精确定位能力，从而提高微创手术中的操作性和控制力。机器人整合将能够高精度地检测难以触及区域的放射性标记组织，消除人为误差，降低术中併发症率，尤其是在对精准度要求极高的复杂癌症手术中。
  • 多重模式和混合成像探头：这一趋势是开发可与其他成像方式（例如超音波或光学成像）结合或整合的伽马探头。混合探头提供互补数据，使外科医生能够同时观察解剖结构和放射性摄取。这种多重模式方案可提供更完整的术中影像，提高诊断准确性，实现更精准的切除，并最大限度地减少多种器械的使用，从而提高手术效率。
  • 提高灵敏度和同位素适用性：伽马探针需要提高灵敏度才能测量更低的放射性水平，从而减少示踪剂的使用，并降低患者和医护人员的辐射暴露。同时，新型、用途更广的探针正在研发中，这些探针可以相容于更广泛的放射性同位素（例如，Technetium-99m、碘-125 和氟-18）。这种灵活性将拓展伽马探针的临床应用范围，使其不再局限于标准的哨兵淋巴结活检，而​​是可以应用于各种核子医学检查。

这些新兴趋势正透过拓展技术创新和临床应用范围，显着改变伽玛探针设备市场。对小型化、无线通讯、机器人整合和多重模式功能的关注，使得手术更加精准、微创和高效。这种变革不仅提高了病人安全性和治疗效果，也增强了伽玛探针在多个医学专科领域的应用，从而推动市场成长，并重塑了放射导航手术的格局。

伽玛探针设备市场近期趋势

伽玛探针产业的最新创新表明，各方正齐心协力地提升其效用、操作性和与现代外科手术通讯协定的兼容性。这些创新源自于肿瘤学及其他依赖放射导引手术的医学领域对精准度日益增长的需求。从改进的检测器技术到更符合人体工学的设计以及专业化的应用，这些进步共同推动了更高效、更精准、更以患者为中心的手术流程，巩固了伽玛探针在现代核医学中的重要地位。

  • 携带式和无线系统的发展：携带式和无线伽玛探针系统的广泛应用和持续改进是该领域的一项重大进展。这些系统提高了手术室内的操作灵活性和便携性，无需繁琐的电缆，并最大限度地缩短了设定时间。其设计、人体工学和易用性为外科医生在诸如前哨淋巴结定位等高级手术中提供了更大的灵活性和精确度，从而简化了手术流程并减少了手术併发症。
  • 提高检测器灵敏度和准直性：目前的研究重点在于优化伽马探针检测器技术，以显着提高灵敏度和空间解析度。这使得能够更精确地探测低活度放射性示踪剂，并更好地区分相邻的放射源。准直器设计的进步进一步提高了方向精度，从而能够精确定位目标组织，同时消除背景辐射干扰，最终获得更有效的手术效果。
  • 推出紧凑型人体工学设计：各公司正致力于开发紧凑型人体工学伽玛探头，以提高使用者在长时间手术过程中的舒适度和易用性。这包括更轻的探头重量、更容易握持的握柄和更人性化的使用者介面。这些特性可减轻外科医师的疲劳，提高手术效率，并达到更精准的术中导航，最终提升手术效果和病人安全。
  • 用于深部病灶和复杂解剖结构的专用探针：最显着的进展之一是开发了专用伽玛探针，这些探针能够到达深部病灶并穿过复杂的解剖区域。这些探针包括加长桿身、倾斜尖端或低轮廓探针，因此能够以微创方式进入以往难以到达的区域。这些客製化设计扩展了伽玛探针的临床应用范围，使其适用于更多类型的癌症和更具挑战性的手术情况，从而改善患者的治疗效果。
  • 先进的软体和数据整合：近期创新成果包括先进的软体平台，可实现即时数据视觉化、定量分析以及与医院资讯系统的无缝整合。这使得放射性计数的即时分析、前哨淋巴结的精确定位以及完整的手术记录成为可能。先进的软体功能简化了工作流程，支援决策制定，从而改善病患管理，并为核子医学领域的研究开闢了新的机会。

这些创新使伽玛探针技术更易于获取、使用和高效，从而对伽玛探针市场产生了重大影响。对便携性、灵敏度提升、符合人体工学的外形设计以及针对特定应用领域的关注，正在提高手术精度和患者疗效，尤其是在肿瘤学领域。与先进软体的整合进一步简化了临床工作流程，推动了整体市场成长，并巩固了伽玛探针作为现代放射导手术必备工具的地位。

目录

第一章执行摘要

第二章 市场概览

  • 背景和分类
  • 供应链

第三章：市场趋势与预测分析

  • 产业驱动因素与挑战
  • PESTLE分析
  • 专利分析
  • 法规环境

4. 全球伽玛探针设备市场依模式类型划分

  • 概述
  • 吸引力分析：按模式划分
  • 独立版：趋势与预测（2019-2031）
  • 行动端：趋势与预测（2019-2031）

5. 全球伽玛探针设备市场（依应用划分）

  • 概述
  • 吸引力分析：依目的
  • 副甲状腺手术：趋势与预测（2019-2031）
  • 前哨淋巴结定位：趋势与预测（2019-2031 年）

6. 全球伽玛探针设备市场（依最终用途划分）

  • 概述
  • 吸引力分析：依最终用途划分
  • 医院：趋势与预测（2019-2031）
  • 门诊手术中心：趋势与预测（2019-2031 年）
  • 其他：趋势与预测（2019-2031 年）

第七章 区域分析

  • 概述
  • 全球伽玛探针设备市场（按地区划分）

7. 北美伽玛探针设备市场

  • 概述
  • 北美伽玛探针设备市场依模式类型划分
  • 北美伽玛探针设备市场依最终用途划分
  • 美国伽玛探针设备市场
  • 墨西哥伽玛探测器设备市场
  • 加拿大伽玛探针设备市场

8. 欧洲伽玛探针设备市场

  • 概述
  • 欧洲伽玛探针设备市场依模式类型划分
  • 欧洲伽玛探针设备市场依最终用途划分
  • 德国伽玛探针设备市场
  • 法国伽玛探测器设备市场
  • 西班牙伽玛探测器设备市场
  • 义大利伽玛探针设备市场
  • 英国伽玛探针设备市场

9. 亚太地区伽玛探测设备市场

  • 概述
  • 亚太地区伽玛探针设备市场依模式类型划分
  • 亚太地区伽玛探针设备市场依最终用途划分
  • 日本伽玛探针设备市场
  • 印度伽玛探针设备市场
  • 中国伽玛探测设备市场
  • 韩国伽玛探针设备市场
  • 印尼伽玛探测器设备市场

10. 其他地区（ROW）伽玛探针设备市场

  • 概述
  • ROW伽玛探针设备市场依模式划分
  • ROW伽玛探针设备市场依最终用途划分
  • 中东伽玛探针设备市场
  • 南美洲伽玛探针设备市场
  • 非洲伽玛探测器设备市场

第十二章 竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析
    • 竞争对手之间的竞争
    • 买方议价能力
    • 供应商的议价能力
    • 替代品的威胁
    • 新进入者的威胁
  • 市占率分析

第十三章：机会与策略分析

  • 价值链分析
  • 成长机会分析
    • 按模式类型分類的成长机会
    • 发展机会：透过申请
    • 按最终用途分類的成长机会
  • 全球伽玛探针设备市场新兴趋势
  • 战略分析
    • 新产品开发
    • 认证和许可
    • 企业合併、协议、合作关係和合资企业

第十四章 价值链中主要企业的概况

  • 竞争分析
  • Hologic
  • Tron Medical
  • Raditec Medical
  • Intramedical Imaging
  • Thermo Fisher Scientific
  • Wake Medical
  • Dilon Technologies

第十五章附录

  • 图表清单
  • 表格列表
  • 分析方法
  • 免责声明
  • 版权
  • 简称和技术单位
  • 关于 Lucintel
  • 询问

The future of the global gamma probe device market looks promising with opportunities in the hospital and ambulatory surgical centre markets. The global gamma probe device market is expected to grow with a CAGR of 8.7% from 2025 to 2031. The major drivers for this market are the increasing demand for precision surgeries, the rising prevalence of cancer cases, and the growing adoption of minimally invasive procedures.

  • Lucintel forecasts that, within the modality type category, mobile is expected to witness higher growth over the forecast period.
  • Within the end use category, the ambulatory surgical centre is expected to witness higher growth.
  • In terms of region, APAC is expected to witness the highest growth over the forecast period.

Emerging Trends in the Gamma Probe Device Market

The gamma probe equipment market is experiencing a profound transformation, influenced by a number of influential emerging trends that highlight precision, integration, and ease of use. Fueled by the ongoing need for less invasive surgery, better diagnostic sensitivity, and improved patient outcomes, especially in oncology, these trends are revolutionizing gamma probe design, functionality, and use, from miniaturization to the use of artificial intelligence. These innovations are driving fundamental change in the design, functionality, and use of gamma probes, and holding out the prospect of a more efficient and effective radiohalo guided surgery future.

  • Miniaturization and Portability: This movement is directed towards creating smaller, lighter, and sometimes wireless gamma probes, and thus more ergonomic and easier to manipulate in the operating theater. Miniaturization permits less invasive surgical techniques and better maneuverability, especially in limited anatomical cavities. The tendency towards portable, handheld devices increases versatility and facilitates utilization across different types of surgeries and environments, minimizing the requirement for cumbersome, trolley-based systems and increasing procedural flexibility and efficiency for surgeons.
  • Wireless and Cordless Technology: The shift to wireless and cordless gamma probes is a major upcoming trend, facilitating greater surgical flexibility and less clutter in the operating room. This technology reduces the hassle of cables, allowing greater mobility for the surgeon and minimizing the risk of contamination or getting stuck during complicated procedures. Wireless connections enable smooth data transmission across display units, which makes the surgical process more streamlined and efficient, thereby making it easier and safer for healthcare personnel.
  • Integration with Robotic Surgical Systems: One of the most significant upcoming trends is the integration of gamma probes seamlessly with robotic surgical systems. This makes it possible for surgeons to use the accurate localization function of gamma probes in a robotic environment, which improves dexterity and control in minimally invasive procedures. Robotic integration is able to provide very accurate detection of radio-labeled tissue in difficult-to-approach areas, eliminating human error and potentially leading to fewer complications during surgery, especially in complicated cancer surgeries where accuracy is critical.
  • Multi-Modality and Hybrid Imaging Probes: This trend is to create gamma probes that can be combined with or incorporate another imaging modality, including ultrasound or optical imaging. Hybrid probes offer complementary data, enabling surgeons to see both anatomical structures and radioactive uptake at the same time. This multi-modality option provides a more complete intraoperative image, enhancing diagnostic accuracy, enabling more accurate resections, and potentially minimizing the use of multiple instruments, resulting in more effective procedures.
  • Increased Sensitivity and Isotopic Versatility: There is ongoing pressure to increase the sensitivity of gamma probes to measure lower radioactivity levels so smaller doses of tracer can be used and radiation exposure to patients and medical personnel can be decreased. In parallel, new probes are being developed to be versatile with a broader selection of radioisotopes (e.g., Technetium-99m, Iodine-125, Fluorine-18). This flexibility broadens the gamma probe's clinical use beyond standard sentinel lymph node biopsies to suit varying nuclear medicine procedures.

These new trends are profoundly transforming the gamma probe device market by advancing the scope of technological innovation and clinical use. The emphasis on miniaturization, wireless communication, robotics integration, and multi-modality functions is resulting in more accurate, less invasive, and highly efficient surgical procedures. This transformation not only improves patient safety and outcomes but also increases the versatility of gamma probes across multiple medical specialties, fueling the growth of the market and reshaping the horizon of radio-guided surgery.

Recent Developments in the Gamma Probe Device Market

Recent innovation in the gamma probe device industry showcases a collaborative effort to improve their utility, usability, and compatibility with contemporary surgical protocols. These innovations are precipitated by the growing need for accuracy in oncology and other such medical disciplines that are dependent on radio-guided surgery. From enhanced detector technology to increased ergonomic design and specialized uses, these advances are cumulatively leading towards more efficient, precise, and patient-centered procedures and thus establishing the gamma probe's indispensable position in modern nuclear medicine.

  • Handheld and Wireless System Development: One of the major developments is the widespread use and ongoing evolution of handheld and wireless gamma probe systems. These systems provide improved mobility and portability within the operating theater, removing the need for cumbersome cables and minimizing setup time. Their design and ergonomics, and ease of use enable surgeons to have more flexibility and accuracy during advanced procedures such as sentinel lymph node mapping, leading to smoother workflows and fewer procedural complications.
  • Enhanced Detector Sensitivity and Collimation: Current developments have centered on maximizing the detector technology of gamma probes to achieve far greater sensitivity and spatial resolution. This enables more precise detection of low-activity radio-tracers and improved discrimination between nearby radioactive sources. Advances in collimator design extend directional precision further, making it possible for the probe to identify the target tissue with great accuracy while filtering out background radiation interference, resulting in more effective surgical outcomes.
  • Compact and Ergonomic Design Introduction: Companies are moving more toward creating gamma probes with compact and ergonomic designs so that user comfort and ease of handling during long surgical operations are enhanced. This involves reduced probe weights, easy-to-handle grips, and user-friendly interfaces. These are features that minimize surgeon fatigue, enhance procedural efficiency, and allow for more accurate intraoperative navigation, ultimately leading to improved surgical performance as well as improved patient safety.
  • Specialized Probes for Deep-Seated Lesions and Difficult Anatomies: One of the most significant developments is the development of specialized gamma probes that can reach deep-seated lesions or traverse difficult anatomical areas. This consists of probes with increased shaft lengths, angled tips, or reduced profiles, allowing for minimally invasive entry into spaces that were historically hard to access. These custom designs extend the clinical value of gamma probes to more types of cancer and challenging surgical situations, enhancing treatment outcomes for patients.
  • Advanced Software and Data Integration: The recent innovations feature advanced software platforms that provide real-time data visualization, quantitative analysis, and seamless integration with hospital information systems. This facilitates real-time interpretation of radioactive counts, accurate mapping of sentinel lymph nodes, and complete documentation of procedures. The advanced software capabilities facilitate workflow, enhance decision-making, and lead to improved patient management and research possibilities in nuclear medicine.

These innovations are significantly influencing the gamma probe device market by increasing accessibility, usability, and efficiency of the technology. Emphasis on portability, sensitivity improvement, ergonomic shapes, and niche applications is enhancing surgical accuracy and patient outcomes, especially in oncology. Integration with advanced software further facilitates clinical workflows, driving the market collectively and reinforcing the gamma probe as an indispensable tool in contemporary radio-guided surgery.

Strategic Growth Opportunities in the Gamma Probe Device Market

The gamma probe device market offers important strategic growth opportunities in many key applications, stimulated by the growing practice of minimally invasive surgery and the widening knowledge of disease development, especially in cancer. These opportunities go far beyond conventional uses, including new areas of diagnosis and treatment. Organizations that are able to develop innovative probe designs, combine with sophisticated imaging, and provide solutions specific to individual clinical requirements will be well placed to grow. Leveraging these application-specific opportunities will help market participants extend their reach and support better patient care.

  • Sentinel Lymph Node Biopsy for Various Cancers: Although SLNB is established in the context of breast cancer and melanoma, the largest growth opportunity resides in its extension to other cancers, such as colorectal, lung, and gynecological cancers. Creation of gamma probes specifically designed for these unique anatomies and distributions of tracers, and with improved sensitivity for multiple isotopes, will fuel adoption. Training programs to educate surgeons about these expanded uses will also play an important role in market penetration and better cancer staging.
  • Parathyroidectomy for Hyperparathyroidism: Gamma probes are increasingly employed in minimally invasive parathyroidectomy surgeries to accurately identify hyperactive parathyroid glands. Opportunities lie in the development of very accurate, small-diameter probes that can selectively identify parathyroid tissue with minimal disturbance to surrounding tissues. As targeted parathyroid surgery becomes more widely understood and recognized, with an aging population, the use of these specialized probes will increase, providing a huge growth segment.
  • Radio-Guided Occult Lesion Localization and Targeted Tumor Resection: In addition to lymph nodes, gamma probes have the potential for growth in the specific localization of occult (non-palpable) lesions and targeted tumor resection, particularly for breast and lung cancer. The advancement of probes with higher spatial resolution and weak radioactive signal detection capabilities will make them more useful in these sensitive procedures. This use diminishes the necessity for excessive dissection, helping to conserve healthy tissue and enhance cosmetic and functional results.
  • Non-Oncology Uses and Research: Although oncology is the leading opportunity, non-cancerous applications are being developed with gamma probes, including orthopedic surgery navigation for bone infections or the detection of inflammatory foci in other specialties. Creating probes that can be specialized for various isotopes and anatomy in these non-oncology applications will create new market niches. In addition, their application in preclinical research with radio-labeled compounds also offers a niche but expanding opportunity, broadening the overall use of the technology.
  • Integration with Intraoperative Imaging and Navigation Systems: Strategic expansion is in the harmonious integration of gamma probes with intraoperative real-time imaging (e.g., ultrasound, optical imaging) and surgical navigation systems. This forms a very effective hybrid method, presenting surgeons with complete anatomical and functional details at the same time. Probes that are made for such integration, with synchronized data presentation and improved guidance, will enhance procedure accuracy and safety, making them an integral part of high-end surgical operating rooms.

These growth opportunities are having a great impact on the gamma probe device market through diversification and specialization of products. Targeting specific medical indications, extending to new forms of cancer, and integrating with higher-end imaging and navigation are allowing companies to improve the accuracy and effectiveness of radio-guided surgery. This focused innovation not only enhances patient outcomes and care but also increases the total addressable market, driving significant growth and reinforcing the gamma probe's central position in contemporary medicine.

Gamma Probe Device Market Driver and Challenges

The gamma probe device market is influenced by an intricate balance of significant drivers and barriers, including numerous technological developments, economic factors, and regulatory issues. These factors in combination determine market growth, innovation, and accessibility direction. Although rising worldwide cancer prevalence and the need for minimally invasive treatments are powerful drivers, the sector must also contend with meaningful barriers in the form of expensive high-end systems, regulatory approval complexities, and radiation exposure worries. Internalizing these complex dynamics is critical to strategic planning.

The factors responsible for driving the gamma probe device market include:

1. Rising Prevalence of Cancer Across the World: The foremost catalyst for the gamma probe device market is the ever-growing world cancer burden. Conditions such as breast carcinoma, melanoma, and thyroid carcinoma, for which sentinel lymph node biopsy is tantamount in staging and therapy, are on the rise. This growing patient population is directly proportional to greater demand for accurate intraoperative localization devices such as gamma probes, making them a vital tool in current oncology.

2. Increased Demand for Minimally Invasive Procedures: There is an increasing trend in the world towards minimally invasive surgical procedures because of their advantages, such as minimal incisions, less pain, quicker recovery, and lower complication rates. Gamma probes play a vital role in navigating these sensitive procedures so that the surgeons can identify target tissues with precision without much dissection. This trend propels the use of gamma probes in different surgical disciplines, boosting the market.

3. Technological Innovation in Probe Design: Ongoing innovation in gamma probe technology, such as enhanced detector sensitivity, miniaturization, weightlessness, and ergonomic designs, plays a key role in promoting market expansion. Such innovations improve precision, convenience, and flexibility, thus making the devices more attractive to surgeons. The fact that they can now detect lower levels of radioactivity and generate faster, more accurate readings further propels their uptake into clinical practice.

4. Growth Applications in Nuclear Medicine: In addition to sentinel lymph node mapping, gamma probes are increasingly being applied in other nuclear medicine interventions, including parathyroidectomy, radio-guided occult lesion localization (ROLL), and intraoperative assessment of tumor margins. This growth in applications increases the market for gamma probes because their usefulness is now applied to different diagnostic and therapeutic interventions, which expands demand in various specialties in medicine.

5. Growing Healthcare Spending and Infrastructure Investment: The growing healthcare spending in the world, especially across developing economies, and substantial investments in upgrading health infrastructure are driving the demand for gamma probes. Enhanced access to better medical facilities and operating theaters, coupled with increasing awareness among healthcare workers regarding radio-guided surgery benefits, leads to higher procurements and applications of gamma probe systems.

Challenges in the gamma probe device market are:

1. Excessive Price of Gamma Probe Devices: The advanced technology and precision work that go into manufacturing gamma probe devices make it relatively expensive to acquire and maintain. This could be a major deterrent, particularly for small hospitals or health facilities with constrained budgets, especially in emerging nations. The prohibitive initial investment can discourage extensive use, affecting market penetration.

2. Stringent Regulatory Approval Processes: The gamma probe device industry is subject to strict regulatory mechanisms around the world, requiring intense testing and clinical verification for new devices. Securing regulatory approvals from regulatory agencies such as the FDA or CE mark could be a long, complicated, and expensive procedure. These strict controls will slow market access for innovative devices and drive up total development costs, representing a major challenge to manufacturers.

3. Radiation Exposure Concerns: Although useful, gamma probes entail the usage of radioactive tracers, and hence, there are concerns related to radiation exposure in patients as well as operating room personnel. Although doses are usually minimal, ongoing concern with radiation hazard can affect patient acceptance as well as clinical acceptance. Creating ultra-sensitive probes with even lesser tracer doses is a continuous challenge to reduce these concerns.

In summary, the gamma probe device market is growing strongly, driven by the growing worldwide cancer burden, the growing demand for minimally invasive procedures, ongoing technology improvements, and growing applications in nuclear medicine. At the same time, this growth is being restrained by some strong challenges, such as the high price of these sophisticated devices, the complexities of tight regulatory approval processes, and persistent issues over radiation exposure. Meeting these challenges with ongoing innovation and targeted market strategies will be key to the market's continued growth and wider use of gamma probe technology in medicine.

List of Gamma Probe Device Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies gamma probe device companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the gamma probe device companies profiled in this report include-

  • Hologic
  • Tron Medical
  • Raditec Medical
  • Intramedical Imaging
  • Thermo Fisher Scientific
  • Wake Medical
  • Dilon Technologies

Gamma Probe Device Market by Segment

The study includes a forecast for the global gamma probe device market by modality type, application, end use, and region.

Gamma Probe Device Market by Modality Type [Value from 2019 to 2031]:

  • Standalone
  • Mobile

Gamma Probe Device Market by Application [Value from 2019 to 2031]:

  • Parathyroid Surgery
  • Sentinel Lymph Node Mapping

Gamma Probe Device Market by End Use [Value from 2019 to 2031]:

  • Hospitals
  • Ambulatory Surgical Centres
  • Others

Country Wise Outlook for the Gamma Probe Device Market

The gamma probe equipment market is undergoing a tremendous transformation, triggered mainly by the rise in the occurrence of cancer worldwide and by the need for accurate, less invasive surgical procedures. Gamma probes are a must-have for nuclear medicine, allowing surgeons to identify accurately sentinel lymph nodes, parathyroid glands, and other radio-tagged tissue during procedures such as sentinel lymph node biopsy for sentinel lymph nodes in different cancers, including melanoma and breast cancer. Current innovations are aimed at increasing portability, sensitivity, and ergonomics for the user, as well as compatibility with robotic surgical systems. Leading nations such as the United States of America, China, Germany, India, and Japan are leading these developments, with the distinct market dynamics within each nation supporting the overall development of this important medical device.

  • United States: The US market for gamma probe devices is dominated by the high usage rate of advanced technology systems, especially in well-known cancer treatment facilities. Product developments are aimed at creating highly sensitive, wireless, and portable probes that provide better intraoperative guidance. Positive reimbursement policies, high research and development expenditures, and the presence of top-tier medical device companies propel ongoing product innovation and expansion in the market. Growing rates of breast cancer and melanoma also fuel demand for sentinel lymph node mapping treatments.
  • China: China is becoming a fast-expanding market for gamma probe instrumentation, backed by expanding healthcare infrastructure, the rise in cancer diagnoses, and growing awareness of advanced surgery methods. Though cost-effectiveness is still a point of consideration, urban hospitals are increasingly demanding updated, efficient gamma probe systems. Domestic producers are enhancing their competency, frequently through joint ventures with foreign firms, in order to accommodate the growing market. Government programs aimed at improving cancer treatment services also play a big role in supporting market growth.
  • Germany: The German gamma probe device market places a focus on accuracy, reliability, and strict clinical standards. The market has a high demand for advanced systems providing better precision and ergonomics, consistent with the advanced healthcare infrastructure of the country. Research and development activities are aimed at enhancing detector technology and combining probes with state-of-the-art imaging modalities for better intraoperative guidance. The established base of specialized cancer centers and skilled nuclear medicine physicians aids in steady market growth.
  • India: The Indian gamma probe device market is witnessing continued growth, driven by the growing incidence of cancer, increasing access to sophisticated medical technology, and expanding healthcare spending. Although cost is a crucial consideration, there is a progressive movement towards adopting advanced gamma probe systems in large city hospitals. Surgeon training for radio-guided surgeries is also contributing to higher adoption of these devices. The expanding medical tourism industry also increases the need for sophisticated surgical equipment.
  • Japan: The gamma probe device market in Japan is marked by its emphasis on technological refinement and miniaturization. The industry leaders among Japanese companies create small, sensitive, and easy-to-use probes that can be well integrated into surgical processes. Demand is fueled by an aging population and a strong focus on accurate surgical procedures, especially in oncology. Studies also investigate multi-modality probes that merge gamma detection with other imaging methods for effective intraoperative information.

Features of the Global Gamma Probe Device Market

  • Market Size Estimates: Gamma probe device market size estimation in terms of value ($B).
  • Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
  • Segmentation Analysis: Gamma probe device market size by modality type, application, end use, and region in terms of value ($B).
  • Regional Analysis: Gamma probe device market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
  • Growth Opportunities: Analysis of growth opportunities in different modality types, applications, end uses, and regions for the gamma probe device market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape of the gamma probe device market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the gamma probe device market by modality type (standalone and mobile), application (parathyroid surgery and sentinel lymph node mapping), end use (hospitals, ambulatory surgical centres, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Market Overview

  • 2.1 Background and Classifications
  • 2.2 Supply Chain

3. Market Trends & Forecast Analysis

  • 3.2 Industry Drivers and Challenges
  • 3.3 PESTLE Analysis
  • 3.4 Patent Analysis
  • 3.5 Regulatory Environment

4. Global Gamma Probe Device Market by Modality Type

  • 4.1 Overview
  • 4.2 Attractiveness Analysis by Modality Type
  • 4.3 Standalone: Trends and Forecast (2019-2031)
  • 4.4 Mobile: Trends and Forecast (2019-2031)

5. Global Gamma Probe Device Market by Application

  • 5.1 Overview
  • 5.2 Attractiveness Analysis by Application
  • 5.3 Parathyroid Surgery: Trends and Forecast (2019-2031)
  • 5.4 Sentinel Lymph Node Mapping: Trends and Forecast (2019-2031)

6. Global Gamma Probe Device Market by End Use

  • 6.1 Overview
  • 6.2 Attractiveness Analysis by End Use
  • 6.3 Hospitals: Trends and Forecast (2019-2031)
  • 6.4 Ambulatory Surgical Centres: Trends and Forecast (2019-2031)
  • 6.5 Others: Trends and Forecast (2019-2031)

7. Regional Analysis

  • 7.1 Overview
  • 7.2 Global Gamma Probe Device Market by Region

8. North American Gamma Probe Device Market

  • 8.1 Overview
  • 8.2 North American Gamma Probe Device Market by Modality Type
  • 8.3 North American Gamma Probe Device Market by End Use
  • 8.4 United States Gamma Probe Device Market
  • 8.5 Mexican Gamma Probe Device Market
  • 8.6 Canadian Gamma Probe Device Market

9. European Gamma Probe Device Market

  • 9.1 Overview
  • 9.2 European Gamma Probe Device Market by Modality Type
  • 9.3 European Gamma Probe Device Market by End Use
  • 9.4 German Gamma Probe Device Market
  • 9.5 French Gamma Probe Device Market
  • 9.6 Spanish Gamma Probe Device Market
  • 9.7 Italian Gamma Probe Device Market
  • 9.8 United Kingdom Gamma Probe Device Market

10. APAC Gamma Probe Device Market

  • 10.1 Overview
  • 10.2 APAC Gamma Probe Device Market by Modality Type
  • 10.3 APAC Gamma Probe Device Market by End Use
  • 10.4 Japanese Gamma Probe Device Market
  • 10.5 Indian Gamma Probe Device Market
  • 10.6 Chinese Gamma Probe Device Market
  • 10.7 South Korean Gamma Probe Device Market
  • 10.8 Indonesian Gamma Probe Device Market

11. ROW Gamma Probe Device Market

  • 11.1 Overview
  • 11.2 ROW Gamma Probe Device Market by Modality Type
  • 11.3 ROW Gamma Probe Device Market by End Use
  • 11.4 Middle Eastern Gamma Probe Device Market
  • 11.5 South American Gamma Probe Device Market
  • 11.6 African Gamma Probe Device Market

12. Competitor Analysis

  • 12.1 Product Portfolio Analysis
  • 12.2 Operational Integration
  • 12.3 Porter's Five Forces Analysis
    • Competitive Rivalry
    • Bargaining Power of Buyers
    • Bargaining Power of Suppliers
    • Threat of Substitutes
    • Threat of New Entrants
  • 12.4 Market Share Analysis

13. Opportunities & Strategic Analysis

  • 13.1 Value Chain Analysis
  • 13.2 Growth Opportunity Analysis
    • 13.2.1 Growth Opportunities by Modality Type
    • 13.2.2 Growth Opportunities by Application
    • 13.2.3 Growth Opportunities by End Use
  • 13.3 Emerging Trends in the Global Gamma Probe Device Market
  • 13.4 Strategic Analysis
    • 13.4.1 New Product Development
    • 13.4.2 Certification and Licensing
    • 13.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

14. Company Profiles of the Leading Players Across the Value Chain

  • 14.1 Competitive Analysis
  • 14.2 Hologic
    • Company Overview
    • Gamma Probe Device Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.3 Tron Medical
    • Company Overview
    • Gamma Probe Device Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.4 Raditec Medical
    • Company Overview
    • Gamma Probe Device Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.5 Intramedical Imaging
    • Company Overview
    • Gamma Probe Device Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.6 Thermo Fisher Scientific
    • Company Overview
    • Gamma Probe Device Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.7 Wake Medical
    • Company Overview
    • Gamma Probe Device Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing
  • 14.8 Dilon Technologies
    • Company Overview
    • Gamma Probe Device Business Overview
    • New Product Development
    • Merger, Acquisition, and Collaboration
    • Certification and Licensing

15. Appendix

  • 15.1 List of Figures
  • 15.2 List of Tables
  • 15.3 Research Methodology
  • 15.4 Disclaimer
  • 15.5 Copyright
  • 15.6 Abbreviations and Technical Units
  • 15.7 About Us
  • 15.8 Contact Us

List of Figures

  • Figure 1.1: Trends and Forecast for the Global Gamma Probe Device Market
  • Figure 2.1: Usage of Gamma Probe Device Market
  • Figure 2.2: Classification of the Global Gamma Probe Device Market
  • Figure 2.3: Supply Chain of the Global Gamma Probe Device Market
  • Figure 3.1: Driver and Challenges of the Gamma Probe Device Market
  • Figure 3.2: PESTLE Analysis
  • Figure 3.3: Patent Analysis
  • Figure 3.4: Regulatory Environment
  • Figure 4.1: Global Gamma Probe Device Market by Modality Type in 2019, 2024, and 2031
  • Figure 4.2: Trends of the Global Gamma Probe Device Market ($B) by Modality Type
  • Figure 4.3: Forecast for the Global Gamma Probe Device Market ($B) by Modality Type
  • Figure 4.4: Trends and Forecast for Standalone in the Global Gamma Probe Device Market (2019-2031)
  • Figure 4.5: Trends and Forecast for Mobile in the Global Gamma Probe Device Market (2019-2031)
  • Figure 5.1: Global Gamma Probe Device Market by Application in 2019, 2024, and 2031
  • Figure 5.2: Trends of the Global Gamma Probe Device Market ($B) by Application
  • Figure 5.3: Forecast for the Global Gamma Probe Device Market ($B) by Application
  • Figure 5.4: Trends and Forecast for Parathyroid Surgery in the Global Gamma Probe Device Market (2019-2031)
  • Figure 5.5: Trends and Forecast for Sentinel Lymph Node Mapping in the Global Gamma Probe Device Market (2019-2031)
  • Figure 6.1: Global Gamma Probe Device Market by End Use in 2019, 2024, and 2031
  • Figure 6.2: Trends of the Global Gamma Probe Device Market ($B) by End Use
  • Figure 6.3: Forecast for the Global Gamma Probe Device Market ($B) by End Use
  • Figure 6.4: Trends and Forecast for Hospitals in the Global Gamma Probe Device Market (2019-2031)
  • Figure 6.5: Trends and Forecast for Ambulatory Surgical Centres in the Global Gamma Probe Device Market (2019-2031)
  • Figure 6.6: Trends and Forecast for Others in the Global Gamma Probe Device Market (2019-2031)
  • Figure 7.1: Trends of the Global Gamma Probe Device Market ($B) by Region (2019-2024)
  • Figure 7.2: Forecast for the Global Gamma Probe Device Market ($B) by Region (2025-2031)
  • Figure 8.1: North American Gamma Probe Device Market by Modality Type in 2019, 2024, and 2031
  • Figure 8.2: Trends of the North American Gamma Probe Device Market ($B) by Modality Type (2019-2024)
  • Figure 8.3: Forecast for the North American Gamma Probe Device Market ($B) by Modality Type (2025-2031)
  • Figure 8.4: North American Gamma Probe Device Market by End Use in 2019, 2024, and 2031
  • Figure 8.5: Trends of the North American Gamma Probe Device Market ($B) by End Use (2019-2024)
  • Figure 8.6: Forecast for the North American Gamma Probe Device Market ($B) by End Use (2025-2031)
  • Figure 8.7: Trends and Forecast for the United States Gamma Probe Device Market ($B) (2019-2031)
  • Figure 8.8: Trends and Forecast for the Mexican Gamma Probe Device Market ($B) (2019-2031)
  • Figure 8.9: Trends and Forecast for the Canadian Gamma Probe Device Market ($B) (2019-2031)
  • Figure 9.1: European Gamma Probe Device Market by Modality Type in 2019, 2024, and 2031
  • Figure 9.2: Trends of the European Gamma Probe Device Market ($B) by Modality Type (2019-2024)
  • Figure 9.3: Forecast for the European Gamma Probe Device Market ($B) by Modality Type (2025-2031)
  • Figure 9.4: European Gamma Probe Device Market by End Use in 2019, 2024, and 2031
  • Figure 9.5: Trends of the European Gamma Probe Device Market ($B) by End Use (2019-2024)
  • Figure 9.6: Forecast for the European Gamma Probe Device Market ($B) by End Use (2025-2031)
  • Figure 9.7: Trends and Forecast for the German Gamma Probe Device Market ($B) (2019-2031)
  • Figure 9.8: Trends and Forecast for the French Gamma Probe Device Market ($B) (2019-2031)
  • Figure 9.9: Trends and Forecast for the Spanish Gamma Probe Device Market ($B) (2019-2031)
  • Figure 9.10: Trends and Forecast for the Italian Gamma Probe Device Market ($B) (2019-2031)
  • Figure 9.11: Trends and Forecast for the United Kingdom Gamma Probe Device Market ($B) (2019-2031)
  • Figure 10.1: APAC Gamma Probe Device Market by Modality Type in 2019, 2024, and 2031
  • Figure 10.2: Trends of the APAC Gamma Probe Device Market ($B) by Modality Type (2019-2024)
  • Figure 10.3: Forecast for the APAC Gamma Probe Device Market ($B) by Modality Type (2025-2031)
  • Figure 10.4: APAC Gamma Probe Device Market by End Use in 2019, 2024, and 2031
  • Figure 10.5: Trends of the APAC Gamma Probe Device Market ($B) by End Use (2019-2024)
  • Figure 10.6: Forecast for the APAC Gamma Probe Device Market ($B) by End Use (2025-2031)
  • Figure 10.7: Trends and Forecast for the Japanese Gamma Probe Device Market ($B) (2019-2031)
  • Figure 10.8: Trends and Forecast for the Indian Gamma Probe Device Market ($B) (2019-2031)
  • Figure 10.9: Trends and Forecast for the Chinese Gamma Probe Device Market ($B) (2019-2031)
  • Figure 10.10: Trends and Forecast for the South Korean Gamma Probe Device Market ($B) (2019-2031)
  • Figure 10.11: Trends and Forecast for the Indonesian Gamma Probe Device Market ($B) (2019-2031)
  • Figure 11.1: ROW Gamma Probe Device Market by Modality Type in 2019, 2024, and 2031
  • Figure 11.2: Trends of the ROW Gamma Probe Device Market ($B) by Modality Type (2019-2024)
  • Figure 11.3: Forecast for the ROW Gamma Probe Device Market ($B) by Modality Type (2025-2031)
  • Figure 11.4: ROW Gamma Probe Device Market by End Use in 2019, 2024, and 2031
  • Figure 11.5: Trends of the ROW Gamma Probe Device Market ($B) by End Use (2019-2024)
  • Figure 11.6: Forecast for the ROW Gamma Probe Device Market ($B) by End Use (2025-2031)
  • Figure 11.7: Trends and Forecast for the Middle Eastern Gamma Probe Device Market ($B) (2019-2031)
  • Figure 11.8: Trends and Forecast for the South American Gamma Probe Device Market ($B) (2019-2031)
  • Figure 11.9: Trends and Forecast for the African Gamma Probe Device Market ($B) (2019-2031)
  • Figure 12.1: Porter's Five Forces Analysis of the Global Gamma Probe Device Market
  • Figure 12.2: Market Share (%) of Top Players in the Global Gamma Probe Device Market (2024)
  • Figure 13.1: Growth Opportunities for the Global Gamma Probe Device Market by Modality Type
  • Figure 13.2: Growth Opportunities for the Global Gamma Probe Device Market by Application
  • Figure 13.3: Growth Opportunities for the Global Gamma Probe Device Market by End Use
  • Figure 13.4: Growth Opportunities for the Global Gamma Probe Device Market by Region
  • Figure 13.5: Emerging Trends in the Global Gamma Probe Device Market

List of Tables

  • Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Gamma Probe Device Market by Modality Type, Application, and End Use
  • Table 1.2: Attractiveness Analysis for the Gamma Probe Device Market by Region
  • Table 1.3: Global Gamma Probe Device Market Parameters and Attributes
  • Table 3.1: Trends of the Global Gamma Probe Device Market (2019-2024)
  • Table 3.2: Forecast for the Global Gamma Probe Device Market (2025-2031)
  • Table 4.1: Attractiveness Analysis for the Global Gamma Probe Device Market by Modality Type
  • Table 4.2: Market Size and CAGR of Various Modality Type in the Global Gamma Probe Device Market (2019-2024)
  • Table 4.3: Market Size and CAGR of Various Modality Type in the Global Gamma Probe Device Market (2025-2031)
  • Table 4.4: Trends of Standalone in the Global Gamma Probe Device Market (2019-2024)
  • Table 4.5: Forecast for Standalone in the Global Gamma Probe Device Market (2025-2031)
  • Table 4.6: Trends of Mobile in the Global Gamma Probe Device Market (2019-2024)
  • Table 4.7: Forecast for Mobile in the Global Gamma Probe Device Market (2025-2031)
  • Table 5.1: Attractiveness Analysis for the Global Gamma Probe Device Market by Application
  • Table 5.2: Market Size and CAGR of Various Application in the Global Gamma Probe Device Market (2019-2024)
  • Table 5.3: Market Size and CAGR of Various Application in the Global Gamma Probe Device Market (2025-2031)
  • Table 5.4: Trends of Parathyroid Surgery in the Global Gamma Probe Device Market (2019-2024)
  • Table 5.5: Forecast for Parathyroid Surgery in the Global Gamma Probe Device Market (2025-2031)
  • Table 5.6: Trends of Sentinel Lymph Node Mapping in the Global Gamma Probe Device Market (2019-2024)
  • Table 5.7: Forecast for Sentinel Lymph Node Mapping in the Global Gamma Probe Device Market (2025-2031)
  • Table 6.1: Attractiveness Analysis for the Global Gamma Probe Device Market by End Use
  • Table 6.2: Market Size and CAGR of Various End Use in the Global Gamma Probe Device Market (2019-2024)
  • Table 6.3: Market Size and CAGR of Various End Use in the Global Gamma Probe Device Market (2025-2031)
  • Table 6.4: Trends of Hospitals in the Global Gamma Probe Device Market (2019-2024)
  • Table 6.5: Forecast for Hospitals in the Global Gamma Probe Device Market (2025-2031)
  • Table 6.6: Trends of Ambulatory Surgical Centres in the Global Gamma Probe Device Market (2019-2024)
  • Table 6.7: Forecast for Ambulatory Surgical Centres in the Global Gamma Probe Device Market (2025-2031)
  • Table 6.8: Trends of Others in the Global Gamma Probe Device Market (2019-2024)
  • Table 6.9: Forecast for Others in the Global Gamma Probe Device Market (2025-2031)
  • Table 7.1: Market Size and CAGR of Various Regions in the Global Gamma Probe Device Market (2019-2024)
  • Table 7.2: Market Size and CAGR of Various Regions in the Global Gamma Probe Device Market (2025-2031)
  • Table 8.1: Trends of the North American Gamma Probe Device Market (2019-2024)
  • Table 8.2: Forecast for the North American Gamma Probe Device Market (2025-2031)
  • Table 8.3: Market Size and CAGR of Various Modality Type in the North American Gamma Probe Device Market (2019-2024)
  • Table 8.4: Market Size and CAGR of Various Modality Type in the North American Gamma Probe Device Market (2025-2031)
  • Table 8.5: Market Size and CAGR of Various End Use in the North American Gamma Probe Device Market (2019-2024)
  • Table 8.6: Market Size and CAGR of Various End Use in the North American Gamma Probe Device Market (2025-2031)
  • Table 8.7: Trends and Forecast for the United States Gamma Probe Device Market (2019-2031)
  • Table 8.8: Trends and Forecast for the Mexican Gamma Probe Device Market (2019-2031)
  • Table 8.9: Trends and Forecast for the Canadian Gamma Probe Device Market (2019-2031)
  • Table 9.1: Trends of the European Gamma Probe Device Market (2019-2024)
  • Table 9.2: Forecast for the European Gamma Probe Device Market (2025-2031)
  • Table 9.3: Market Size and CAGR of Various Modality Type in the European Gamma Probe Device Market (2019-2024)
  • Table 9.4: Market Size and CAGR of Various Modality Type in the European Gamma Probe Device Market (2025-2031)
  • Table 9.5: Market Size and CAGR of Various End Use in the European Gamma Probe Device Market (2019-2024)
  • Table 9.6: Market Size and CAGR of Various End Use in the European Gamma Probe Device Market (2025-2031)
  • Table 9.7: Trends and Forecast for the German Gamma Probe Device Market (2019-2031)
  • Table 9.8: Trends and Forecast for the French Gamma Probe Device Market (2019-2031)
  • Table 9.9: Trends and Forecast for the Spanish Gamma Probe Device Market (2019-2031)
  • Table 9.10: Trends and Forecast for the Italian Gamma Probe Device Market (2019-2031)
  • Table 9.11: Trends and Forecast for the United Kingdom Gamma Probe Device Market (2019-2031)
  • Table 10.1: Trends of the APAC Gamma Probe Device Market (2019-2024)
  • Table 10.2: Forecast for the APAC Gamma Probe Device Market (2025-2031)
  • Table 10.3: Market Size and CAGR of Various Modality Type in the APAC Gamma Probe Device Market (2019-2024)
  • Table 10.4: Market Size and CAGR of Various Modality Type in the APAC Gamma Probe Device Market (2025-2031)
  • Table 10.5: Market Size and CAGR of Various End Use in the APAC Gamma Probe Device Market (2019-2024)
  • Table 10.6: Market Size and CAGR of Various End Use in the APAC Gamma Probe Device Market (2025-2031)
  • Table 10.7: Trends and Forecast for the Japanese Gamma Probe Device Market (2019-2031)
  • Table 10.8: Trends and Forecast for the Indian Gamma Probe Device Market (2019-2031)
  • Table 10.9: Trends and Forecast for the Chinese Gamma Probe Device Market (2019-2031)
  • Table 10.10: Trends and Forecast for the South Korean Gamma Probe Device Market (2019-2031)
  • Table 10.11: Trends and Forecast for the Indonesian Gamma Probe Device Market (2019-2031)
  • Table 11.1: Trends of the ROW Gamma Probe Device Market (2019-2024)
  • Table 11.2: Forecast for the ROW Gamma Probe Device Market (2025-2031)
  • Table 11.3: Market Size and CAGR of Various Modality Type in the ROW Gamma Probe Device Market (2019-2024)
  • Table 11.4: Market Size and CAGR of Various Modality Type in the ROW Gamma Probe Device Market (2025-2031)
  • Table 11.5: Market Size and CAGR of Various End Use in the ROW Gamma Probe Device Market (2019-2024)
  • Table 11.6: Market Size and CAGR of Various End Use in the ROW Gamma Probe Device Market (2025-2031)
  • Table 11.7: Trends and Forecast for the Middle Eastern Gamma Probe Device Market (2019-2031)
  • Table 11.8: Trends and Forecast for the South American Gamma Probe Device Market (2019-2031)
  • Table 11.9: Trends and Forecast for the African Gamma Probe Device Market (2019-2031)
  • Table 12.1: Product Mapping of Gamma Probe Device Suppliers Based on Segments
  • Table 12.2: Operational Integration of Gamma Probe Device Manufacturers
  • Table 12.3: Rankings of Suppliers Based on Gamma Probe Device Revenue
  • Table 13.1: New Product Launches by Major Gamma Probe Device Producers (2019-2024)
  • Table 13.2: Certification Acquired by Major Competitor in the Global Gamma Probe Device Market